Latest return on equity
Metagenomi Therapeutics Return on equity
Metagenomi Therapeutics (MGX) return on equity with its verified observation da…
Direct answer
Metagenomi Therapeutics's return on equity is -60.61%.
The verified market snapshot reports -60.61%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked August 29, 2026.
Get free Metagenomi Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- -60.61%
Explore related company data
View Metagenomi Therapeutics's market capitalizationView Metagenomi Therapeutics's price-to-book ratioView Metagenomi Therapeutics's 52-week price rangeView Metagenomi Therapeutics's profit marginView Metagenomi Therapeutics's debt-to-equity ratioView all Metagenomi Therapeutics key metricsReturn to Metagenomi Therapeutics profile